Insight Molecular Diagnostics Inc.
IMDXNASDAQHealthcare● Active
$5.98
+$0.26(+4.60%)
Market Cap$160592473
P/E Ratio—
52W High$8.51
52W Low$2.33
Insight Molecular Diagnostics Inc. (IMDX) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IMDX · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $11.58M | $8.64M | $9.43M | $20.43M | $33.85M |
| Net Receivables | $1.13M | $1.61M | $0.48M | $2.01M | $1.44M |
| Inventory | $0.45M | $0.41M | $0.00M | $0.00M | $0.30M |
| Total Current Assets | $15.31M | $11.76M | $10.70M | $25.54M | $39.14M |
| PP&E Net | $2.81M | $2.76M | $5.44M | $10.85M | $8.37M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $18.68M |
| Intangible Assets | $0.00M | $14.61M | $56.59M | $61.63M | $61.72M |
| Total Assets | $25.76M | $35.08M | $74.89M | $100.09M | $159.56M |
| Liabilities | |||||
| Short-Term Debt | $1.81M | $0.00M | $0.00M | $0.00M | $1.31M |
| Accounts Payable | $2.54M | $2.28M | $0.95M | $1.25M | $1.81M |
| Total Current Liabilities | $12.07M | $7.28M | $7.19M | $12.11M | $14.12M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $57.22M | $47.35M | $54.42M | $60.50M | $94.35M |
| Stockholders Equity | |||||
| Retained Earnings | ($400.76M) | ($350.54M) | ($289.88M) | ($260.68M) | ($187.77M) |
| Total Stockholders Equity | ($31.46M) | ($12.27M) | $20.47M | $39.59M | $65.22M |
| Total Liab & Equity(computed) | $25.76M | $35.08M | $74.89M | $100.09M | $159.56M |
| Debt Summary | |||||
| Total Debt | $3.50M | $3.66M | $2.87M | $3.54M | $5.68M |
| Net Debt | ($8.09M) | ($4.97M) | ($6.56M) | ($16.45M) | ($27.27M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Insight Molecular Diagnostics Inc. data
About Insight Molecular Diagnostics Inc. (IMDX) Balance Sheet
Insight Molecular Diagnostics Inc. (IMDX) balance sheet shows total assets of $0.03B with cash of $0.01B. Total liabilities are $0.06B, total debt $0.00B, and stockholders equity ($0.03B).
Frequently asked questions
IMDX · 4 questionsInsight Molecular Diagnostics Inc. has total debt of $0.00B with net debt of ($0.01B).
IMDX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10